MONDAY, Aug. 30, 2021 (HealthDay News) — Treatment with two monoclonal antibodies lowers the odds of hospitalization for high-risk COVID-19 patients with mild to moderate illness, according to a new study. “Our conclusion overall at this point is that monoclonal antibodies are an important option in treatment to reduce theContinue Reading

FRIDAY, Aug. 27, 2021 (HealthDay News) — A first-of-a-kind nerve stimulation treatment for people who have problems moving their arms after a stroke has been approved by the U.S. Food and Drug Administration. “People who have lost mobility in their hands and arms due to ischemic stroke are often limitedContinue Reading